OptiBiotix tumbles as it warns of 'materially lower' sales
24th Aug 2022 15:38
(Sharecast News) - Life sciences company OptiBiotix Health said in a trading update on Wednesday that, based on initial figures, it expected first-half sales in its new structure to be "materially lower than expected" at around £0.12m.
Read moreOptiBiotix set to list ProBiotix subsidiary on AQSE
17th Mar 2022 16:37
(Sharecast News) - OptiBiotix Health announced its intention to list its subsidiary ProBiotix Health on the AQSE Growth Market of the Aquis Stock Exchange on Thursday.
Read moreOptiBiotix Health ends year in line with expectations
28th Feb 2022 14:24
(Sharecast News) - OptiBiotix Health updated the market on its trading ahead of its final results on Monday, reporting total invoiced sales of £2.2m in 2021 - an increase of 46.7% year-on-year, and in line with market expectations.
Read moreOptiBiotix lays out strategy for investment and growth
9th Feb 2022 11:56
(Sharecast News) - Life sciences company OptiBiotix Health updated the market on its strategic and commercial progress on Wednesday, reporting that the next phase of its strategy would involve reinvesting proceeds from the recent sale of SkinBioTherapeutics shares, which generated £2m.
Read moreOptiBiotix signs supply deal with Saudi Arabia chemist chain
15th Dec 2021 14:45
(Sharecast News) - Life sciences company OptiBiotix Health has signed an exclusive supply agreement with pharmacy chain Nahdi Medical, it announced on Wednesday, for the sales of its 'GoFigure' and 'SlimBiome Medical' weight management products in Saudi Arabia.
Read moreOptiBiotix signs deal with massive chemist chain in India
9th Dec 2021 15:37
(Sharecast News) - OptiBiotix Health said on Thursday that its India subsidiary has signed an exclusive sales agreement with one of the leading hospital and pharmacy chains in the country, Apollo Hospitals Enterprises, for the sale of its 'GoFigure' weight management product range in India.
Read moreOptiBiotix Health forms operating subsidiary in India
17th Nov 2021 10:56
(Sharecast News) - Life sciences company OptiBiotix Health announced the formation of its new India subsidiary OptiBiotix Health India (OHI) on Wednesday.
Read moreDirector dealings: Optibiotix CEO ups stake
1st Sep 2021 15:46
(Sharecast News) - Optibiotix Health revealed on Wednesday that chief executive René Kamminga had purchased 8,188 ordinary shares in the AIM-listed life sciences firm.
Read moreOptiBiotix extends deal with Seed Health to other territories
10th Aug 2021 11:24
(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has extended the territories of its original agreement with Seed Health, for the production, promotion, marketing and commercialisation of products containing 'LPLDL'.
Read moreOptiBiotix revenues see healthy rise in first half
5th Aug 2021 13:43
(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.
Read moreOptiBiotix operating losses narrow as revenue surges
17th Jun 2021 12:13
(Sharecast News) - Life sciences company OptiBiotix Health reported a 104% improvement in its full-year revenue on Thursday, to £1.52m.
Read moreOptibiotix names René Kamminga as CEO of subsidiary
23rd Mar 2021 08:06
(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.
Read moreOptiBiotix grants LPLDL licence to Canada's Genuine Health
18th Nov 2020 12:23
(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.
Read moreOptiBiotix products launch into retail in Australia, New Zealand
12th Oct 2020 14:00
(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.
Read moreOptiBiotix shares rise as partner Seed gets FDA approval
2nd Oct 2020 10:17
(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.
Read more